MedPath

Preventive effect of rabeprazole and sucralfate on gastroduodenal mucosal injury in patients taking low-dose aspiri

Not Applicable
Conditions
Patients who have plan to receive low-dose aspirin
Registration Number
JPRN-UMIN000001678
Lead Sponsor
Department of Internal Medicine, Teikyo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.taking low-dose aspirin 2.below 20 years of age 3.contraindication against rabeprazole and sucralfate 4.malignancy 5.pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of endoscopic finding before and 4 weeks after initiating low-dose aspirin (Comparison between rabeprazole and sucralfate)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath